Literature DB >> 10564868

A new arthroscopic method for reconstructing the anterior and posterior cruciate ligaments using a single-incision technique: simultaneous grafting of the autogenous semitendinosus and patellar tendons.

K Hara1, T Kubo, C Shimizu, T Suginoshita, G Minami, Y Hirasawa.   

Abstract

We established a simultaneous reconstruction method for ruptured anterior and posterior cruciate ligaments (ACL, PCL) using a single-incision technique. Residual PCL was used to determine the position of bone tunnel for ACL reconstruction. The bone tunnel position on the tibia for PCL reconstruction was arthroscopically confirmed by conducting through debridement from the posteromedial portal. Reconstruction substitutes were patellar-tendon bone-tendon-bone for ACL, and semitendinosus tendon for PCL. In the fixation procedure, the PCL substitute was fixed using the Endobutton (Smith & Nephew, Andover, MA) and a ceramic button, and the ACL substitute was fixed with an interference screw. During the surgery, radiographic monitoring and the PCL guide system were not required.

Entities:  

Mesh:

Year:  1999        PMID: 10564868     DOI: 10.1053/ar.1999.v15.015087

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  2 in total

1.  Evaluation of the vascular status of autogenous hamstring tendon grafts after anterior cruciate ligament reconstruction in humans using magnetic resonance angiography.

Authors:  Yuji Arai; Kunio Hara; Takeshi Takahashi; Hidenori Urade; Ginjiro Minami; Hisatake Takamiya; Toshikazu Kubo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-01-09       Impact factor: 4.342

2.  Arthroscopically assisted combined anterior and posterior cruciate ligament reconstruction with autologous hamstring grafts-isokinetic assessment with control group.

Authors:  Tomasz Piontek; Kinga Ciemniewska-Gorzela; Andrzej Szulc; Jakub Naczk; Martyna Wardak; Tadeusz Trzaska; Witold Dudzinski; Monika Grygorowicz
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.